Schedule 13D ownership disclosure

LA JOLLA PHARMACEUTICAL CO

Security class unavailable · CUSIP: 503459604

Event date: 2022-08-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,504,791
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000941560-22-000010
Form type
SC 13D
Filer
GARDNER LEWIS ASSET MANAGEMENT L P
CIK
CIK 941560
Filed
Aug 29, 2022
Reporting period
Aug 16, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub